biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Daiichi Countdown Alert: 15 business days left!

<< Previous

Bullboard Posts

Next >>

Comment by KayakerBCon Mar 27, 2022 10:17am

137 Views

Post# 34549610

RE:RE:RE:RE:RE:RE:RE:RE:Daiichi Countdown Alert: 15 business days left!

Oh geez, the resident pumper/dumper has a pulse. Who knew.

I see from your response that you didn't understand my post. Not a surprise. You'd have to have a conscience.

I don't give a hoot if you participated in the contest. But we both know your guess would have been just as far off as anyone else's. So when you try to take advantage of that by taking cheap shots at people who did participate, I'll point out how pathetic it is. Too bad if that's a problem for you.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing